Cited by 1,023TGF-β signaling in diseasesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Open access

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology

DOI 10.1016/j.it.2010.04.002PMC PMC2891151

Open this paper in CoChat — free account

Abstract

Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor microenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.it.2010.04.002

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
IL-17 and th17 cells
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,470
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087

Show all 87 references

Sorted by citations

Items 401–500 of 1,000

The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
Hasselbalch, H. C. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.07.006 · Cited by 29
p53 mutation and deletion contribute to tumor immune evasion
Liu, S. M., Liu, T., Jiang, J., Guo, H., & Yang, R. L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1088455 · Cited by 31
Functional Nanomaterials Optimized to Circumvent Tumor Immunological Tolerance
Gong, N., Zhang, Y., Zhang, Z., Li, X., & Liang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806087 · Cited by 29
Dramatically changed immune‐related molecules as early diagnostic biomarkers of non‐small cell lung cancer
Ye, X., Zhang, N., Jin, Y., Xu, B., Guo, C., Wang, X., Su, Y., Yang, Q., Song, J., Yu, W., et al. (2019) · FEBS Journal · doi:10.1111/febs.15051 · Cited by 28
miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease
Han, S. A., Jhun, B. W., Kim, S., Moon, S. M., Yang, B., Kwon, O. J., Daley, C. L., Shin, S. J., & Koh, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-60132-0 · Cited by 28
Monocytes and Macrophages in Cancer: Unsuspected Roles
Gouveia-Fernandes, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_9 · Cited by 28
Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors
Chen, J. A., Ma, W., Yuan, J. D., & Li, T. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_9 · Cited by 29
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Lv, L., Zhao, Y., Wei, Q., Zhao, Y., & Yi, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01298-5 · Cited by 28
Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer
Li, K., Xu, J., Wang, J., Lu, C., Dai, Y., Dai, Q., Zhang, W., Xu, C., Wu, S., & Kang, Y. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03290-6 · Cited by 29
Natural killer cell immunotherapy in glioblastoma
Hosseinalizadeh, H., Roudkenar, M. H., Roushandeh, A. M., Kuwahara, Y., Tomita, K., & Sato, T. (2022) · Discover Oncology · doi:10.1007/s12672-022-00567-1 · Cited by 28
Impaired gp100-Specific CD8+ T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model
Mairhofer, D. G., Ortner, D., Tripp, C. H., Schaffenrath, S., Fleming, V., Heger, L., Komenda, K., Reider, D., Dudziak, D., Chen, S., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.241 · Cited by 28
Phytoestrogen calycosin-7-O-β-D-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage
Xu, Y., Feng, L., Wang, S., Zhu, Q., Lin, J., Lou, C., Xiang, P., He, B., Zheng, Z., Tang, D., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23212 · Cited by 28
Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?
Cui, G., Shi, Y., Cui, J., Fuai, T., & Florholmen, J. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.648950 · Cited by 29
Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy
Komorowski, M. P., McGray, A. R., Kołakowska, A., Eng, K. H., Gil, M., Opyrchal, M., Litwińska, B., Nemeth, M. J., Odunsi, K. O., & Kozbor, D. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.34 · Cited by 28
Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update
Shi, Y., Li, Z., Zheng, W., Liu, X., Sun, C., Laugsand, J.-B., Liu, Z., & Cui, G. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.003 · Cited by 28
A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma
Rolfe, N. W., Dadario, N. B., Canoll, P., & Bruce, J. N. (2024) · Pharmaceuticals · doi:10.3390/ph17080973 · Cited by 27
Role of Smad7 in inflammatory bowel diseases
Monteleone, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i40.5664 · Cited by 26
Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer
Bryant, G., Wang, L., & Mulholland, D. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071542 · Cited by 30
E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
Sinha, A., Iyengar, P. V., & ten Dijke, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020476 · Cited by 30
TGF‐β isoforms inhibit hepatitis C virus propagation in transforming growth factor beta/SMAD protein signalling pathway dependent and independent manners
Zou, L., Li, J., Li, H., Tan, J., Wang, M., Liu, N., Gao, R., Yan, H., Wang, X., Dong, B., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16432 · Cited by 27
MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc mice
Liu, N., Steer, C. J., & Song, G. (2021) · Hepatology · doi:10.1002/hep.32182 · Cited by 27
SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer
Li, X., Jing, L., Mou, K., Peng, L., Zhou, H., Lei, Y., Wang, H., Zhao, Z., Wang, J., Wu, J., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83012 · Cited by 27
Knockdown of BAMBI inhibits β-catenin and transforming growth factor β to suppress metastasis of gastric cancer cells
Liu, K., Song, X., Ma, H., LIU, L., WEN, X., Yu, J., WANG, L., & Hu, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2305 · Cited by 27
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Setsu, G., Goto, M., Ito, K., Taira, T., Miyamoto, M., Watanabe, T., Taniguchi, T., Umezaki, Y., Nakazawa, Y., Uesugi, S., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176184 · Cited by 26
In Vivo Regulation of TGF-β by R-Ras2 Revealed through Loss of the RasGAP Protein NF1
Patmore, D. M., Welch, S., Fulkerson, P. C., Wu, J., Choi, K., Eaves, D. W., Kordich, J. J., Collins, M. H., Cripe, T. P., & Ratner, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1972 · Cited by 26
Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence
Khorsandi, S. E., & Heaton, N. D. (2016) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2016.03.18 · Cited by 26
Synergetic roles of TGF-β signaling in tissue engineering
Kwak, E., & Lee, N. Y. (2019) · Cytokine · doi:10.1016/j.cyto.2018.12.010 · Cited by 26
Antitumor immunity of low-dose cyclophosphamide: changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis
Huang, X.-M., Zhang, N.-R., Lin, X., Zhu, C.-Y., Zou, Y., Wu, X., He, X., He, X., Wan, Y.-L., & Lan, P. (2019) · Gastroenterology report · doi:10.1093/gastro/goz060 · Cited by 26
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Mojsilović, S. B., Mojsilović, S. S., Bjelica, S., & Santibanez, J. F. (2021) · Developmental Dynamics · doi:10.1002/dvdy.339 · Cited by 27
Negative regulation of TGF-β by AMPK and implications in the treatment of associated disorders
Gao, J., Ye, J., Ying, Y., Lin, H., & Luo, Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy028 · Cited by 28
Impact of PD‐L1, transforming growth factor‐β expression and tumor‐infiltrating CD8+ T cells on clinical outcome of patients with advanced thymic epithelial tumors
Duan, J., Liu, X., Chen, H., Sun, Y., Liu, Y., Bai, H., & Wang, J. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12826 · Cited by 26
CCL9/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-β
Niu, B., Tian, T., Wang, L., Tian, Y., Tian, T., Guo, Y., Zhou, H., & Zhang, Z. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.009 · Cited by 25
ResolVI: addressing noise and bias in spatial transcriptomics
Ergen, C., & Yosef, N. (2026) · Nature Methods · doi:10.1038/s41592-026-03212-9 · Cited by 26
L1CAM Overexpression Promotes Tumor Progression Through Recruitment of Regulatory T Cells in Esophageal Carcinoma
Zhao, X., Liu, S., Chen, X., Zhao, J., Li, F., Zhao, Q., Xie, T., Huang, L., Zhang, Z., Qi, Y., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0182 · Cited by 25
Nanotechnology synergized immunoengineering for cancer
Chauhan, D. S., Dhasmana, A., Laskar, P., Prasad, R., Jain, N. K., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.010 · Cited by 27
Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression
Alsamraae, M., Costanzo-Garvey, D. L., Teply, B. A., Boyle, S., Sommerville, G., Herbert, Z. T., Morrissey, C. M., Dafferner, A. J., Abdalla, M. Y., Fallet, R. W., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216468 · Cited by 28
TGF-β Converts Apoptotic Stimuli into the Signal for Th9 Differentiation
Takami, M., Love, R. B., & Iwashima, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102698 · Cited by 25
NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula
Luo, Y., Wu, J., Zhu, X., Gong, C., Yao, C., Ni, Z., Wang, L., Ni, L., Li, Y., & Zhu, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3541283 · Cited by 25
TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs
Tang, P. M., Tang, P. C., Chung, J. Y., & Lan, H.-Y. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.04.001 · Cited by 25
Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
Rossowska, J., Anger, N., Szczygieł, A., Mierzejewska, J., & Pajtasz‐Piasecka, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00713 · Cited by 26
MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol
Michaille, J., Piurowski, V., Rigot, B., Kelani, H., Fortman, E. C., & Tili, E. (2018) · Medicines · doi:10.3390/medicines5030074 · Cited by 25
Anti-Inflammatory Effect of an Apigenin-Maillard Reaction Product in Macrophages and Macrophage-Endothelial Cocultures
Zhou, Q., Xu, H., Yu, W., Li, E., & Wang, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9026456 · Cited by 25
The conditional role of inflammation in pregnancy and cancer
Soeters, P. B., & Grimble, R. F. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.07.010 · Cited by 24
Checkpoint Inhibitors in Bladder and Renal Cancers: Results and Perspectives
Aoun, F. Y., Kourié, H. R., Sideris, S., Roumeguère, T., van Velthoven, R., & Gil, T. (2015) · Immunotherapy · doi:10.2217/imt.15.91 · Cited by 24
TGFβ Programs Central Memory Differentiation in Ex Vivo –Stimulated Human T Cells
Dahmani, A., Janelle, V., Carli, C., Richaud, M., Lamarche, C., Khalili, M., Goupil, M., Bezverbnaya, K., Bramson, J. L., & Delisle, J. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0691 · Cited by 27
Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
Jang, A., Adler, D. M., Rauterkus, G. P., Bilen, M. A., & Barata, P. C. (2021) · Cancers · doi:10.3390/cancers13205065 · Cited by 26
Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era
Shimozaki, K., Nakayama, I., Hirota, T., & Yamaguchi, K. (2023) · Cells · doi:10.3390/cells12071049 · Cited by 25
Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy
Pan, W., Bian, C., Zou, G.-L., Zhang, C., Hai, P., Zhao, R., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19032 · Cited by 24
Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis
Vitiello, G. A. F., Guembarovski, R. L., Hirata, B. K. B., Amarante, M. K., de Oliveira, C. E. C., de Oliveira, K. B., Cebinelli, G. C. M., Guembarovski, A. L., Campos, C. Z., & Watanabe, M. A. E. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2585-9 · Cited by 24
Reactive stroma and trastuzumab resistance in HER2‐positive early breast cancer
Sonnenblick, A., Salmon‐Divon, M., Salgado, R., Dvash, E., Ponde, N. F., Zahavi, T., Salmon, A. Y., Loibl, S., Denkert, C., Joensuu, H., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32859 · Cited by 23
Genetic variants shape rheumatoid arthritis-specific transcriptomic features in CD4+ T cells through differential DNA methylation, explaining a substantial proportion of heritability
Ha, E., Bang, S., Lim, J., Yun, J. H., Kim, J., Bae, J.-B., Lee, H., Kim, B.-J., Kim, K.-W., & Bae, S. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219152 · Cited by 24
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment
Zhu, Y., Borgogno, S. F., Sheng, J., Yeung, T.-L., Burks, J. K., Cappello, P., Jazaeri, A. A., Kim, J., Han, G. H., Birrer, M. J., et al. (2021) · Cancers · doi:10.3390/cancers13081777 · Cited by 26
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
Wang, K., Zerdes, I., Johansson, H. J., Sarhan, D., Sun, Y., Kanellis, D. C., Sifakis, E. G., Mezheyeuski, A., Liu, X., Loman, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47932-y · Cited by 22
The role of transforming growth factor-β (TGF-β) in the formation of exhausted CD8 + T cells
Ma, R., Sun, J., & Wang, Y. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01394-0 · Cited by 27
YAP/TAZ, beta-catenin, and TGFb pathway activation in medical plasma-induced wound healing in diabetic mice
Schmidt, A., von Woedtke, T., Weltmann, K., & Bekeschus, S. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.004 · Cited by 23
Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea
Weinberger, V., Darnhofer, B., Thapa, H. B., Mertelj, P., Stentz, R., Jones, E. J., Grabmann, G., Mohammadzadeh, R., Shinde, T., Karner, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60271-w · Cited by 30
Modelling TGFβR and Hh pathway regulation of prognostic matrisome molecules in ovarian cancer
Delaine‐Smith, R. M., Maniati, E., Malacrida, B., Nichols, S., Roozitalab, R., Jones, R. R., Lecker, L. S. M., Pearce, O. M. T., Knight, M. M., & Balkwill, F. R. (2021) · iScience · doi:10.1016/j.isci.2021.102674 · Cited by 24
AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF‐β/Smad signalling in hepatocellular carcinoma
Chung, J. Y., Chan, M. K., Tang, P. C., Chan, A. S. W., Chung, J. S., Meng, X., To, K., Lan, H. Y., Leung, K. T., & Tang, P. M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16928 · Cited by 24
Modulation of Immune Components on Stem Cell and Dormancy in Cancer
Jiang, X., Liang, L., Chen, G., & Liu, C. (2021) · Cells · doi:10.3390/cells10112826 · Cited by 22
Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma
Wu, H., Wei, M., Li, Y., Ma, Q., & Zhang, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.910543 · Cited by 26
A polymeric IDO inhibitor based on poly(ethylene glycol)- b -poly( l -tyrosine- co -1-methyl- d -tryptophan) enables facile trident cancer immunotherapy
Liu, Y., Xie, J., Zhao, X., Zhang, Y., Zhong, Z., & Deng, C. (2022) · Biomaterials Science · doi:10.1039/d2bm01181f · Cited by 23
The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma
Wu, W., Li, H., Wang, Z., Dai, Z., Liang, X., Luo, P., Liu, K., Zhang, H., Zhang, N., Li, S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23915 · Cited by 24
Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model
Chen, Y.-S., Huang, T., Liu, C., Chen, H., Lee, M.-H., Chen, H., & Shen, C. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.104 · Cited by 23
Identification of Novel Tumor-Microenvironment-Regulating Factor That Facilitates Tumor Immune Infiltration in Colon Cancer
Wang, Y., Wang, Y., Xu, C., Liu, Y., & Huang, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.029 · Cited by 23
Epithelial immune cell-like transition (EIT): A proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers
Choi, S. Y. C., Gout, P. W., Collins, C. C., & Wang, Y. Z. (2012) · Differentiation · doi:10.1016/j.diff.2012.02.005 · Cited by 23
Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model
Chen, L., Lin, Z., He, W., Qiu, M., Gao, L., Liu, J., & Huang, A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00283.2013 · Cited by 23
Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities
Zhang, W., Jin, C., Liu, S., Wan, X., Li, Y., Liu, J., Duan, Z., Ma, J., & Gao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1757513 · Cited by 22
Self-citation
Current data and future perspectives on DNA methylation in ovarian cancer (Review)
Fu, M., Deng, F., Chen, J., Fu, L., Lei, J., Xu, T., Chen, Y., Zhou, J., Gao, Q., & Ding, H. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5650 · Cited by 23
Aptamers as potential therapeutic agents for ovarian cancer
Henri, J., MacDonald, J. P., Strom, M., Duan, W., & Shigdar, S. L. (2017) · Biochimie · doi:10.1016/j.biochi.2017.12.001 · Cited by 22
Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction
Zhang, J., Zuo, T., Yang, J., Hu, Z., Wang, Z., Xu, R., Ma, S., Wei, Y., & Shen, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c18545 · Cited by 21
Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
Onwudiwe, K. C., Najera, J., Siri, S., & Datta, M. (2022) · Cells · doi:10.3390/cells11233840 · Cited by 22
The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
Tanjak, P., Chaiboonchoe, A., Suwatthanarak, T., Acharayothin, O., Thanormjit, K., Chanthercrob, J., Suwatthanarak, T., Wannasuphaphol, B., Chumchuen, K., Suktitipat, B., et al. (2023) · Cancers · doi:10.3390/cancers15041098 · Cited by 24
Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
Gu, Y., Zhang, Z., Camps, M. G. M., OSSENDORP, F. A., Wijdeven, R. H. M., & ten Dijke, P. (2023) · Science Advances · doi:10.1126/sciadv.adf9915 · Cited by 23
An overview of extracellular matrix and its remodeling in the development of cancer and metastasis with a glance at therapeutic approaches
Afshar, K., Sanaei, M., Ravari, M. S., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3846 · Cited by 23
Regulation of epithelial cell turnover and macrophage phenotype by epithelial cell-derived transforming growth factor beta1 in the mammary gland
Sun, X., Robertson, S. A., & Ingman, W. V. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.002 · Cited by 22
The Role of Interleukin-17A in Colorectal Tumorigenesis
Shi, Y., Lin, H., Cui, J., Qi, H., Florholmen, J., Liu, Z., & Cui, G. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1396 · Cited by 22
Have Cells Harboring the HIV Reservoir Been Immunoedited?
Huang, S.-H., McCann, C. D., Mota, T. M., Wang, C., Lipkin, S. M., & Jones, R. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01842 · Cited by 23
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer
Riso, P. L., Villa, C. E., Gasparoni, G., Vingiani, A., Luongo, R., Manfredi, A., Jungmann, A., Bertolotti, A., Borgo, F., Garbi, A., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00786-7 · Cited by 22
Cytokine modulation in pelvic organ prolapse and urinary incontinence: from molecular insights to therapeutic targets
Chen, Y., Ullah, A., Chen, W., Xuan, J., Huang, X., Liang, S., Shen, B., & Wu, T. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00989-3 · Cited by 21
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 28
Pancreatic cancer, treatment options, and GI-4000
Hartley, M. L., Bade, N. A., Prins, P., Ampie, L., & Marshall, J. L. (2014) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2014.1004017 · Cited by 21
A kinetic model of multiple phenotypic states for breast cancer cells
Qiu, K., Gao, K., Yang, L., Zhang, Z.-K., Wang, R., Ma, H., & Jia, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-10321-1 · Cited by 20
Self-citation
Fueling chimeric antigen receptor T cells with cytokines.
Jin, J., Cheng, J., Huang, M., Luo, H., & Zhou, J. (2020) · PubMed Central · Cited by 21
Infection in the Developing Brain: The Role of Unique Systemic Immune Vulnerabilities
Singh, G., Tucker, E. W., & Rohlwink, U. K. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.805643 · Cited by 25
Breaking tumor-induced immunosuppression with 5′-triphosphate siRNA silencing TGFβ and activating RIG-I
Schnurr, M. M., & Duewell, P. (2013) · OncoImmunology · doi:10.4161/onci.24170 · Cited by 21
Nanomaterials for Enhanced Immunity as an Innovative Paradigm in Nanomedicine
Seth, A., Oh, D., & Lim, Y. T. (2015) · Nanomedicine · doi:10.2217/nnm.14.200 · Cited by 21
ALK1 heterozygosity delays development of late normal tissue damage in the irradiated mouse kidney
Scharpfenecker, M., Floot, B., Korlaar, R., Russell, N. S., & Stewart, F. A. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.061 · Cited by 21
The Numbers of FoxP3+ Lymphocytes in Sentinel Lymph Nodes of Breast Cancer Patients Correlate With Primary Tumor Size but Not Nodal Status
Gupta, R., Babb, J. S., Singh, B., Chiriboga, L. A., Liebes, L., Adams, S., & Demaria, S. (2011) · Cancer Investigation · doi:10.3109/07357907.2011.585193 · Cited by 21
The role of transforming growth factor β in upper gastrointestinal cancers: A systematic review
Veen, L. M., Skrabanja, T. L. P., Derks, S., de Gruijl, T. D., Bijlsma, M. F., & van Laarhoven, H. W. M. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102285 · Cited by 21
Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis
Czaja, A. J. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06968-6 · Cited by 21
LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression
Tang, P. C., Zhang, Y.-Y., Li, J. S.-F., Chan, M. K., Chan, M. K., Tang, Y., Zhou, Y., Zhang, D., Leung, K., To, K., et al. (2022) · Non-Coding RNA · doi:10.3390/ncrna8030036 · Cited by 20
An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-β1-driven immune suppression
Shin, S. H., Lee, Y. E., Yoon, H., Yuk, C. M., An, J. Y., Seo, M., Yoon, S. W., Oh, M.-S., Shin, S. C., Kim, J. H., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122888 · Cited by 21
Functional study of immature dendritic cells co-transfected with IL-10 and TGF-beta 1 genes in vitro
Chen, L., Qiu, M., He, W., Huang, A., & Liu, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1468-4 · Cited by 20
Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study
Guo, J., Zhang, P., Zhou, L., You, L., Liu, Q., Zhang, Z., Sun, B., Liang, Z.-Y., Lü, J., Yuan, D., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102767 · Cited by 20
Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis
Zare, S., Kabiri, M., Amini, Y., Najafi, A., Mohammadpour, F., Ayati, S. H., Nikpoor, A. R., & Tafaghodi, M. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02146-z · Cited by 20
TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer
Ma, H., Wei, Y., Leng, Y., Li, S., Gao, L., Hu, H., Chen, L., Wang, F., Xiao, H., Zhu, C., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0019-3 · Cited by 20
Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
Song, Y., Liu, Y., Teo, H. Y., & Liu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914839 · Cited by 22
Adverse Renal Effects of Anticancer Immunotherapy: A Review
Borówka, M., Łącki-Zynzeling, S., Nicze, M., Kozak, S., & Chudek, J. T. (2022) · Cancers · doi:10.3390/cancers14174086 · Cited by 22
Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study
Zheng, P., Tan, Y., Liu, Q., Wu, C., Kang, J., Liang, S., Zhu, L., Yan, K., Zeng, L., & Chen, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26993 · Cited by 19
Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer
Liu, H., Liu, Y., Kong, F., Xin, W., Li, X., Liang, H., & Jia, Y. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.02.023 · Cited by 19

Authors: Yang, L., Pang, Y., & Moses, H. L.
Affiliations: National Institutes of Health (US)
Vanderbilt University (US)
ORCID: Pang, Yanli
Moses, Harold L.
Venue: Trends in Immunology
Publisher: Elsevier BV
Published: 2010-06
Volume: 31
Issue: 6
Pages: 220-227
ISSN: 1471-4906 (ISSN-L)
DOI: 10.1016/j.it.2010.04.002
PMC: PMC2891151
OpenAlex: W2130229338
Cited by: 1,023
References: 87
Citations by year: 2026: 35 · 2025: 73 · 2024: 81 · 2023: 82 · 2022: 87 · 2021: 96 · 2020: 85 · 2019: 78 · 2018: 71 · 2017: 51 · 2016: 37 · 2015: 40 · 2014: 49 · 2013: 50 · 2012: 56
FWCI: 4.42
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (ZIABC011163)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: TGF-beta, tumor microenvironment, tumor progression, immunosuppression, tumor surveillance, CD8+ T cells, natural killer cells, neutrophils, chemokines, cancer-associated fibroblasts, TGF-beta antagonists
MeSH terms: Animals, Humans, Killer Cells, Natural, Neoplasms, T-Lymphocytes, Signal Transduction, Transforming Growth Factor beta, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks